Cycle Pharmaceuticals Partners With Forma Life Sciences for CAVHANZA Supply
IRVINE, Calif., August 12, 2026 Cycle Pharmaceuticals announced a commercial manufacturing agreement with Forma Life Sciences to establish a...
Pharmaceutical Industry
Advertisement
Teva Earns Investment-Grade Rating as Growth Strategy Advances
TEL AVIV, Israel, August 11, 2026 Teva Pharmaceutical Industries Ltd. announced that Moody’s Ratings has upgraded the company’s corporate...
Grifols Completes SPARTA Phase 3 Trial of Prolastin-C
Bridgewater, N.J., August 10, 2026 Grifols announced the completion of patient follow-up in SPARTA, its Phase 3 outcomes study...
Amneal Completes Kashiv BioSciences Acquisition to Expand Biosimilars
Bridgewater, N.J., August 10, 2026 Amneal Pharmaceuticals, Inc. has completed its acquisition of Kashiv BioSciences, LLC, creating a scaled,...
Angelini Pharma Completes $4.1 Billion Acquisition of Catalyst Pharmaceuticals
ROME & CORAL GABLES, Fla., July 16, 2026 Angelini Pharma has completed its acquisition of Catalyst Pharmaceuticals, marking a...
Advertisements
Bayer Secures €3 Billion Apollo Investment for LARC Business
LEVERKUSEN, Germany, July 10, 2026 Bayer AG has announced a landmark €3.0 billion equity investment agreement with global asset...
Novo Nordisk’s Denecimig Shows Strong Phase 3 Hemophilia Data
PLAINSBORO, New Jersey, USA / BAGSVÆRD, Denmark, July 11, 2026 Novo Nordisk has announced positive long-term Phase 3 results...
FDA Proposes New Rule to Modernize Drug Manufacturing
SILVER SPRING, Maryland, July 10, 2026 The U.S. Food and Drug Administration (FDA) has proposed a new rule designed...
5W AI Index Reveals New Pharma Visibility Leaders Online
BOCA RATON, Fla., June 19, 2026 5W AI Communications has released its Pharma / Rx AI Visibility Index 2026,...
Lupin and Natco Win U.S. FDA Approval for Eribulin Injection
MUMBAI, India & NAPLES, Florida, USA, June 3, 2026 Lupin Limited and its alliance partner Natco Pharma have announced...
Advertisement
